Rhenman & Partners Asset Management AB

Holdings History for Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)

Symbol: SAGE
Investment type: Equity / Common Stock, par value $0.0001 per share (the "Common Stock")

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Mar 2022		-0.33%	$0	0	-115,000	-100%	$14.85	Q1 2022
31 Dec 2021	0.33%	0%	$4,974,000	115,000	0		$43.25	Q4 2021
30 Sep 2021	0.36%	+0.12%	$5,096,000	115,000	+40,000	+53%	$44.31	Q3 2021
30 Jun 2021	0.29%	+0.29%	$4,261,000	75,000	+75,000	NEW	$56.81	Q2 2021
30 Jun 2020		-0.2%	$0	0	-50,000	-100%	$14.85	Q2 2020
31 Mar 2020	0.2%	0%	$1,436,000	50,000	0		$28.72	Q1 2020
31 Dec 2019	0.4%	+0.24%	$3,610,000	50,000	+30,000	+150%	$72.20	Q4 2019
30 Sep 2019	0.35%	-0.03%	$2,806,000	20,000	-1,639	-7.6%	$140.30	Q3 2019
30 Jun 2019	0.45%	-0.62%	$3,962,000	21,639	-30,000	-58%	$183.10	Q2 2019
31 Mar 2019	0.96%	-1.6%	$8,213,000	51,639	-85,700	-62%	$159.05	Q1 2019
31 Dec 2018	1.5%	+0.14%	$13,156,000	137,339	+12,600	+10%	$95.79	Q4 2018
30 Sep 2018	1.8%	-0.07%	$17,619,000	124,739	-4,940	-3.8%	$141.25	Q3 2018
30 Jun 2018	2.1%	+0.56%	$20,299,000	129,679	+34,679	+37%	$156.53	Q2 2018
31 Mar 2018	1.9%	-0.2%	$15,302,000	95,000	-9,930	-9.5%	$161.07	Q1 2018
31 Dec 2017	2.3%	+1.2%	$17,283,000	104,930	+54,930	+110%	$164.71	Q4 2017
30 Sep 2017	0.4%	0%	$3,115,000	50,000	0		$62.30	Q3 2017
30 Jun 2017	0.57%	-0.26%	$3,982,000	50,000	-22,659	-31%	$79.64	Q2 2017
31 Mar 2017	0.82%	+0.82%	$5,164,000	72,659	+72,659	NEW	$71.07	Q1 2017

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.